Takara Bio
33 articles about Takara Bio
-
Takara Bio USA, Inc. and bioSyntagma, Inc. Develop Method for Large-Scale Automated COVID-19 Testing
6/8/2020
Takara Bio USA, Inc. (TBUSA), a pioneering life science instrument and reagent company and wholly owned subsidiary of Takara Bio Inc., collaborated with bioSyntagma, Inc. and their partners to develop and validate a new high-throughput method for detecting SARS-CoV-2. The method employs automation technology and reagents from TBUSA to detect viral RNA via real-time PCR and will enable rapid, large-scale testing of tho
-
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
5/21/2020
AGC Biologics, a global Contract Development and Manufacturing Organization for Biopharmaceuticals, has announced its partnership with Takara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.
-
Takara Bio And Formulatrix Announce Partnership To Increase Researcher’s Single-Cell Sequencing Throughput
6/21/2017
-
WaferGen Biosystems Announces Stockholder Approval Of Merger With Takara Bio
11/16/2016
-
WaferGen Biosystems And Takara Bio Announce Exclusive Distribution Agreement For Japan
6/7/2016
-
WaferGen Biosystems And Takara Bio Announce Merger Agreement
5/13/2016
-
Takara Bio Gobbles Up WaferGen Biosystems in $50 Million All-Cash Deal
5/13/2016
-
Cellectis Announces RetroNectin Supply And License Agreement With Takara Bio
3/22/2016
-
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Licenses Cell Differentiation Technology To Takara Bio
11/16/2015
-
Takara Bio Selects Genedata Software To Automate And Standardize NGS Data Analysis
11/5/2014
-
Takara Bio Selects Genedata AG Software To Automate And Standardize NGS Data Analysis
11/5/2014
-
Cellectis Announces The Closing Of The Sale Of Its Swedish Subsidiary Cellectis AB To Takara Bio
9/4/2014
-
Cellectis Sells Its Swedish Unit To Takara Bio For Undisclosed Amount
7/29/2014
-
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan
12/5/2012
-
Exiqon A/S and Takara Bio Partner on the Distribution of miRCURY LNA Products in Asia
10/17/2012
-
Takara Bio Europe Offers Real-Time PCR Training Webinars in Collaboration with World-Class Provider, TATAA Biocenter
2/21/2012
-
NuGEN Technologies, Inc. Announces Takara Bio as Japanese Distributor
6/9/2010
-
Takara Bio to Enter into a Collaborative Research Agreement with University of Pennsylvania, Aiming for a Future Clinical Trial of HIV Gene Therapy
3/12/2010
-
Roche Diagnostics Corporation (JOBS) Licenses Melting Curve Analysis and SYBR Green Techniques to Takara Bio
12/17/2009
-
Takara Bio Reports on Cancer Drug Trial in China
5/5/2008